|
MechanismATP synthase inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanism1-acylglycerol-3-phosphate O-acyltransferase PNPLA3 inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with FASgen, Inc.
0 Patents (Medical) associated with FASgen, Inc.
100 Deals associated with FASgen, Inc.
100 Translational Medicine associated with FASgen, Inc.